Stimulus-induced gamma rhythms are weaker in human elderly with Mild Cognitive Impairment and Alzheimer's Disease

  1. Dinavahi VPS Murty
  2. Keerthana Manikandan
  3. Wupadrasta Santosh Kumar
  4. Ranjini Garani Ramesh
  5. Simran Purokayastha
  6. Bhargavi Nagendra
  7. Abhishek M. L.
  8. Aditi Balakrishnan
  9. Mahendra Javali
  10. Naren Prahalada Rao
  11. Supratim Ray  Is a corresponding author
  1. Indian Institute of Science, India
  2. MS Ramaiah Medical College & Memorial Hospital, India
  3. National Institute of Mental Health and Neurosciences, India

Abstract

Alzheimer's Disease (AD) in elderly adds substantially to socio-economic burden necessitating early diagnosis. While recent studies in rodent models of AD have suggested diagnostic and therapeutic value for gamma rhythms in brain, the same has not been rigorously tested in humans. In this case-control study, we recruited a large population (N=244; 106 females) of elderly (>49 years) subjects from the community, who viewed large gratings that induced strong gamma oscillations in their electroencephalogram (EEG). These subjects were classified as healthy (N=227), mild-cognitively-impaired (MCI; N=12) or AD (N=5) based on clinical history and Clinical Dementia Rating scores. Surprisingly, stimulus-induced gamma rhythms, but not alpha or steady-state visually evoked responses, were significantly lower in MCI/AD subjects compared to their age and gender matched controls. This reduction was not due to differences in eye-movements or baseline power. Our results suggest that gamma could be used as potential screening tool for MCI/AD in humans.

Data availability

All spectral analyses were performed using Chronux toolbox (version 2.10), available at http://chronux.org. Relevant data and codes are available at the following GitHub repository: https://github.com/supratimray/TLSAEEGProjectPrograms.

Article and author information

Author details

  1. Dinavahi VPS Murty

    Centre for Neuroscience, Indian Institute of Science, Bengaluru, India
    Competing interests
    The authors declare that no competing interests exist.
  2. Keerthana Manikandan

    Centre for Neuroscience, Indian Institute of Science, Bengaluru, India
    Competing interests
    The authors declare that no competing interests exist.
  3. Wupadrasta Santosh Kumar

    Centre for Neuroscience, Indian Institute of Science, Bengaluru, India
    Competing interests
    The authors declare that no competing interests exist.
  4. Ranjini Garani Ramesh

    Centre for Neuroscience, Indian Institute of Science, Bengaluru, India
    Competing interests
    The authors declare that no competing interests exist.
  5. Simran Purokayastha

    Centre for Neuroscience, Indian Institute of Science, Bengaluru, India
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6096-1477
  6. Bhargavi Nagendra

    Centre for Neuroscience, Indian Institute of Science, Bengaluru, India
    Competing interests
    The authors declare that no competing interests exist.
  7. Abhishek M. L.

    Centre for Neuroscience, Indian Institute of Science, Bengaluru, India
    Competing interests
    The authors declare that no competing interests exist.
  8. Aditi Balakrishnan

    Centre for Neuroscience, Indian Institute of Science, Bengaluru, India
    Competing interests
    The authors declare that no competing interests exist.
  9. Mahendra Javali

    Department of Neurology, MS Ramaiah Medical College & Memorial Hospital, Bangalore, India
    Competing interests
    The authors declare that no competing interests exist.
  10. Naren Prahalada Rao

    Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India
    Competing interests
    The authors declare that no competing interests exist.
  11. Supratim Ray

    Centre for Neuroscience, Indian Institute of Science, Bengaluru, India
    For correspondence
    sray@iisc.ac.in
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1968-1382

Funding

Tata Trusts

  • Naren Prahalada Rao
  • Supratim Ray

Wellcome Trust/DBT India Alliance (Intermediate fellowship 500145/Z/09/Z)

  • Supratim Ray

Wellcome Trust/DBT India Alliance (Senior fellowship IA/S/18/2/504003)

  • Supratim Ray

Department of Biotechnology, Ministry of Science and Technology, India (DBT-IISc Partnership Programme)

  • Supratim Ray

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: We obtained informed consent from all participants before the experiment. The Institute Human Ethics Committees of Indian Institute of Science (IHEC numbers: original: 22/2014, revised: 7-15092017), NIMHANS, and M S Ramaiah Hospital, Bangalore approved all procedures.

Reviewing Editor

  1. Martin Vinck, Ernst Strüngmann Institute (ESI) for Neuroscience in Cooperation with Max Planck Society, Germany

Publication history

  1. Received: July 31, 2020
  2. Accepted: May 23, 2021
  3. Accepted Manuscript published: June 8, 2021 (version 1)
  4. Version of Record published: June 28, 2021 (version 2)

Copyright

© 2021, Murty et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,660
    Page views
  • 388
    Downloads
  • 9
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Dinavahi VPS Murty
  2. Keerthana Manikandan
  3. Wupadrasta Santosh Kumar
  4. Ranjini Garani Ramesh
  5. Simran Purokayastha
  6. Bhargavi Nagendra
  7. Abhishek M. L.
  8. Aditi Balakrishnan
  9. Mahendra Javali
  10. Naren Prahalada Rao
  11. Supratim Ray
(2021)
Stimulus-induced gamma rhythms are weaker in human elderly with Mild Cognitive Impairment and Alzheimer's Disease
eLife 10:e61666.
https://doi.org/10.7554/eLife.61666

Further reading

    1. Epidemiology and Global Health
    2. Medicine
    Sonali Amarasekera, Prabhat Jha
    Insight

    Individuals recently diagnosed with a cardiovascular disease are at higher risk of developing a mental illness, with mortality increasing when both conditions are present.

    1. Cell Biology
    2. Medicine
    Sharon Elliot, Paola Catanuto ... Marilyn K Glassberg
    Research Article

    Background:

    MicroRNAs (miRNA) and other components contained in extracellular vesicles may reflect the presence of a disease. Lung tissue, sputum, and sera of individuals with idiopathic pulmonary fibrosis (IPF) show alterations in miRNA expression. We designed this study to test whether urine and/or tissue derived exosomal miRNAs from individuals with IPF carry cargo that can promote fibrosis.

    Methods:

    Exosomes were isolated from urine (U-IPFexo), lung tissue myofibroblasts (MF-IPFexo), serum from individuals with IPF (n=16) and age/sex-matched controls without lung disease (n=10). We analyzed microRNA expression of isolated exosomes and their in vivo bio-distribution. We investigated the effect on ex vivo skin wound healing and in in vivo mouse lung models.

    Results:

    U-IPFexo or MF-IPFexo expressed miR-let-7d, miR-29a-5p, miR-181b-3p and miR-199a-3p consistent with previous reports of miRNA expression obtained from lung tissue/sera from patients with IPF. In vivo bio-distribution experiments detected bioluminescent exosomes in the lung of normal C57Bl6 mice within 5 min after intravenous infusion, followed by distribution to other organs irrespective of exosome source. Exosomes labeled with gold nanoparticles and imaged by transmission electron microscopy were visualized in alveolar epithelial type I and type II cells. Treatment of human and mouse lung punches obtained from control, non-fibrotic lungs with either U-IPFexo or MF-IPFexo produced a fibrotic phenotype. A fibrotic phenotype was also induced in a human ex vivo skin model and in in vivo lung models.

    Conclusions:

    Our results provide evidence of a systemic feature of IPF whereby exosomes contain pro-fibrotic miRNAs when obtained from a fibrotic source and interfere with response to tissue injury as measured in skin and lung models.

    Funding:

    This work was supported in part by Lester and Sue Smith Foundation and The Samrick Family Foundation and NIH grants R21 AG060338 (SE and MKG), U01 DK119085 (IP, RS, MTC).